Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.05B |
| 2 |
Texas Instruments
TXN
|
+$1.69B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Starbucks
SBUX
|
+$1.2B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$949M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.77B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.22B |
| 4 |
iShares US Real Estate ETF
IYR
|
+$1.11B |
| 5 |
Procter & Gamble
PG
|
+$915M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.33% |
| 2 | Consumer Discretionary | 7.25% |
| 3 | Financials | 7.18% |
| 4 | Communication Services | 6.16% |
| 5 | Healthcare | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
DigitalOcean
DOCN
$14.4B
| $978K | ﹤0.01% |
28,149
-35,846
| -56% | -$1.28M |
|
2527
Enerpac Tool Group
EPAC
$1.92B
| $978K | ﹤0.01% |
25,603
-32,987
| -56% | -$1.22M |
|
2528
STAAR Surgical
STAA
$1.15B
| $972K | ﹤0.01% |
20,406
-26,148
| -56% | -$1.15M |
|
2529
Cushman & Wakefield Ltd
CWK
$3.2B
| $970K | ﹤0.01% |
93,310
-63,773
| -41% | -$659K |
|
2530
Concentrix
CNXC
$1.61B
| $968K | ﹤0.01% |
15,303
-31,301
| -67% | -$1.88M |
|
2531
Strategic Education
STRA
$1.86B
| $967K | ﹤0.01% |
8,741
-11,856
| -58% | -$1.31M |
|
2532
Kforce
KFRC
$1.05B
| $964K | ﹤0.01% |
15,509
-8,314
| -35% | -$528K |
|
2533
CALL
GSK
GSK
$104B
| $963K | ﹤0.01% |
+25,000
| New | +$1.05M |
|
2534
Collegium Pharmaceutical
COLL
$944M
| $958K | ﹤0.01% |
29,761
-17,403
| -37% | -$603K |
|
2535
Stock Yards Bancorp
SYBT
$2.61B
| $957K | ﹤0.01% |
19,264
-15,954
| -45% | -$744K |
|
2536
McGrath RentCorp
MGRC
$2.97B
| $957K | ﹤0.01% |
8,980
-15,044
| -63% | -$1.66M |
|
2537
Rogers Corp
ROG
$2.39B
| $957K | ﹤0.01% |
7,933
-7,715
| -49% | -$905K |
|
2538
Midland States Bancorp
MSBI
$701M
| $955K | ﹤0.01% |
42,142
-14,908
| -26% | -$343K |
|
2539
Cohen & Steers
CNS
$4.34B
| $954K | ﹤0.01% |
13,149
-14,176
| -52% | -$1.01M |
|
|
AMED
2540
DELISTED
Amedisys
AMED
| $954K | ﹤0.01% |
10,387
-31,915
| -75% | -$2.96M |
|
2541
Old Second Bancorp
OSBC
$1.31B
| $952K | ﹤0.01% |
64,305
-27,099
| -30% | -$381K |
|
2542
Arcutis Biotherapeutics
ARQT
$3.31B
| $950K | ﹤0.01% |
102,113
+3,608
| +4% | +$32.6K |
|
2543
MannKind Corp
MNKD
$1.24B
| $949K | ﹤0.01% |
181,744
-93,323
| -34% | -$423K |
|
2544
MasterBrand
MBC
$1.15B
| $948K | ﹤0.01% |
64,610
-141,584
| -69% | -$2.34M |
|
|
HEES
2545
DELISTED
H&E Equipment Services
HEES
| $945K | ﹤0.01% |
21,401
-14,924
| -41% | -$765K |
|
|
LB
2546
LandBridge Co
LB
$2.24B
| $944K | ﹤0.01% |
+40,778
| New | +$944K |
|
2547
John Wiley & Sons Class A
WLY
$2.72B
| $943K | ﹤0.01% |
23,179
-36,146
| -61% | -$1.38M |
|
2548
Descartes Systems
DSGX
$6.67B
| $943K | ﹤0.01% |
9,738
+6,022
| +162% | +$566K |
|
2549
Janus International
JBI
$760M
| $942K | ﹤0.01% |
74,607
-44,434
| -37% | -$621K |
|
2550
Byline Bancorp
BY
$1.79B
| $942K | ﹤0.01% |
39,687
-14,279
| -26% | -$318K |
|
Similar funds
Barclays's Q2 2024 Portfolio in Review
As of Q2 2024, Barclays held 5,455 positions worth $327B, up 14% from $288B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Barclays deployed $29.4B of net new capital in Q2 2024, opening 406 new positions and adding to 1,053 existing holdings. Its largest new stake was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Apple, an estimated $2.77B trimmed.
- Barclays's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
- Barclays added most to CRH in Q2 2024, an estimated $2.05B increase.
- Barclays's biggest Q2 2024 reduction was Apple, cutting an estimated $2.77B.
- Barclays fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $212M.
- Barclays's ten largest holdings make up 42% of its $327B portfolio in Q2 2024.
- Barclays opened 406 new positions and closed 646 in Q2 2024.
- Barclays's portfolio value rose 14% quarter-over-quarter to $327B.
Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.